Tolerance in Allogeneic Living-Related Renal Transplantation:

Univ Europeenne - EAN : 9783330869158
Aruna V. Vanikar
Édition papier

EAN : 9783330869158

Paru le : 2 mai 2017

49,90 € 47,30 €
Disponible
Pour connaître votre prix et commander, identifiez-vous
Notre engagement qualité
  • Benefits Livraison gratuite
    en France sans minimum
    de commande
  • Benefits Manquants maintenus
    en commande
    automatiquement
  • Benefits Un interlocuteur
    unique pour toutes
    vos commandes
  • Benefits Toutes les licences
    numériques du marché
    au tarif éditeur
  • Benefits Assistance téléphonique
    personalisée sur le
    numérique
  • Benefits Service client
    Du Lundi au vendredi
    de 9h à 18h
  • EAN13 : 9783330869158
  • Réf. fournisseur : 1933825
  • Editeur : Univ Europeenne
  • Date Parution : 2 mai 2017
  • Disponibilite : Disponible
  • Barème de remise : NS
  • Nombre de pages : 116
  • Format : H:229 mm L:152 mm E:7 mm
  • Poids : 182gr
  • Interdit de retour : Retour interdit
  • Résumé : Transplantation tolerance may be defined as normal graft survival sans immunosuppression, maintaining intact immunity. Tolerance induction (TI) strategies include induction of chimerism and/or clonal deletion. Donor specific transfusion (DST) and stem cells (SCs) have come-up as TI. In this parallel 2-armed open labeled study under non-myeloablative conditioning with DST as first arm and SCs as second arm, without using conventional immunosuppression. Monitoring included SCr (mg/dL), DSA and MLR. Protocol biopsies were planned after 100 days and yearly in willing patients. In event of rejection/DSA/MLR, rescue immunosuppression was planned. Patient survival for the first 2 years was 100% in both arms; at 5 years post-transplant 80% with SC and 90% with DST. Death-censored graft survival for 1st year was 100 % in both arms, and at 5 years, 80% with SC and 70% with DST. Mean SCr was 1.52 with SC and 1.97 with DST. Five patients from SC-arm and 3 from DST-arm had successful TI. MLR was negative in both groups. DSA appeared in 2 patients of SC without graft dysfunction and 4 of DST causing graft dysfunction. Thus SCs facilitate TI in LDRT under non-myeloablative conditioning.
Haut de page
Copyright 2026 Cufay. Tous droits réservés.